Aonofriesei Florin
Department of Natural Sciences, Faculty of Natural and Agricultural Sciences, Ovidius University of Constanta, 1, University Street, 900470 Constanța, Romania.
Pharmaceutics. 2024 May 15;16(5):657. doi: 10.3390/pharmaceutics16050657.
The capacity of micro-organisms to form biofilms is a pervasive trait in the microbial realm. For pathogens, biofilm formation serves as a virulence factor facilitating successful host colonization. Simultaneously, infections stemming from biofilm-forming micro-organisms pose significant treatment challenges due to their heightened resistance to antimicrobial agents. Hence, the quest for active compounds capable of impeding microbial biofilm development stands as a pivotal pursuit in biomedical research. This study presents findings concerning the impact of three surfactants, namely, polysorbate 20 (T20), polysorbate 80 (T80), and sodium dodecyl sulfate (SDS), on the initial stage of biofilm development in both and In contrast to previous investigations, we conducted a comparative assessment of the biofilm development capacity of these two taxonomically distant groups, predicated on their shared ability to reduce TTC. The common metabolic trait shared by and in reducing TTC to formazan facilitated a simultaneous evaluation of biofilm development under the influence of surfactants across both groups. Our results revealed that surfactants could impede the development of biofilms in both species by disrupting the initial cell attachment step. The observed effect was contingent upon the concentration and type of compound, with a higher inhibition observed in culture media supplemented with SDS. At maximum concentrations (5%), T20 and T80 significantly curtailed the formation and viability of and biofilms. Specifically, T20 inhibited biofilm development by 75.36% in and 71.18% in , while T80 exhibited a slightly lower inhibitory effect, with values ranging between 66.68% () and 65.54% () compared to the controls. Incorporating these two non-toxic surfactants into pharmaceutical formulations could potentially enhance the inhibitory efficacy of selected antimicrobial agents, particularly in external topical applications.
微生物形成生物膜的能力是微生物领域中一种普遍存在的特性。对于病原体而言,生物膜的形成是一种毒力因子,有助于成功定殖于宿主。同时,由形成生物膜的微生物引起的感染因其对抗菌剂的抗性增强而带来了重大的治疗挑战。因此,寻找能够阻碍微生物生物膜形成的活性化合物是生物医学研究中的一项关键追求。本研究呈现了关于三种表面活性剂,即聚山梨醇酯20(T20)、聚山梨醇酯80(T80)和十二烷基硫酸钠(SDS),对[具体两种微生物名称未给出]生物膜形成初始阶段影响的研究结果。与先前的研究不同,我们基于这两个分类学上差异较大的群体在还原TTC方面的共同能力,对它们的生物膜形成能力进行了比较评估。[具体两种微生物名称未给出]在将TTC还原为甲臜方面共有的代谢特性,使得能够同时评估这两个群体在表面活性剂影响下的生物膜形成情况。我们的结果表明,表面活性剂可通过破坏初始细胞附着步骤来阻碍这两种物种生物膜的形成。观察到的效果取决于化合物的浓度和类型,在添加SDS的培养基中观察到更高的抑制作用。在最大浓度(5%)时,T20和T80显著减少了[具体两种微生物名称未给出]生物膜的形成和活力。具体而言,T20在[具体微生物名称1未给出]中抑制生物膜形成75.36%,在[具体微生物名称2未给出]中抑制71.18%,而T80的抑制作用略低,与对照相比,其值在66.68%([具体微生物名称1未给出])和65.(此处原文有误,推测应为65.54%)([具体微生物名称2未给出])之间。将这两种无毒表面活性剂纳入药物制剂中可能会增强所选抗菌剂的抑制效果,特别是在外部局部应用中。